Submitted by the St. Clair County Health Department:
Since November 2020, monoclonal antibody therapy has been a safe and highly effective treatment for high-risk individuals who are experiencing mild to moderately severe COVID-19.
The FDA recently announced that Sotrovimab is currently the only remaining effective monoclonal antibody treatment against the Omicron variant of the SARS-CoV-2 virus. Sotrovimab is currently in short supply across the United States, including Michigan and therefore, strict criteria for eligibility is currently in effect.
Priority eligibility criteria for therapeutics, including antiviral medication and monoclonal antibody therapy will remain in effect until supply is able to meet demand and will be periodically reviewed as appropriate:
-
Any age (per applicable EUA or FDA approval) with a moderate to severe immunocompromised condition regardless of vaccine status or
- Age>75 YO and not up to date on COVID vaccines or
- Age 65-74 YO, not up to date on COVID vaccines, and with MI priority risk factor as described above or
- Pregnant and not up to date on COVID vaccines
Dr. Annette Mercatante, Medical Health Officer at the St. Clair County Health Department stated, “Our local community infusion center, operated by Tri-Hospital EMS, has had to shift with this change. Quantities of Sotrovimab are limited and a strict criteria for eligibility is being used to maximize its use. We will expand this criteria as soon as possible to include a larger group of people.” Mercatante continued, “Talk to your doctor about what treatment options are best and available for you. The St. Clair County Health Department (SCCHD) continues to strongly recommend getting vaccinated and boosted for the best protection against the virus.”
Email COVID-19 questions to covid19@stclaircounty.org or call (810) 966-4163. For more COVID-19 information visit the health department website www.scchealth.co and social media @scchdmi.
